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Abstract: A novel highly biocompatible near infrared nanosized contrast agent was developed 
and used for rapid tumor detection and quantification using planar optical imaging and analysis. 
With this in mind, the near infrared fluorescent dye Alexa 750 was covalently attached to poly-
ethylene glycol-phosphatidylethanolamine (PEG-PE) conjugate, and double labeled (with Alexa 
and rhodamine) PEG-PE micelles were injected into mice and observed using planar optical 
imaging. Pixel intensity data from the tumor site were normalized versus the autofluorescence 
of the animal at the same time point and normalized as signal to noise over the scattered light 
from the various tissues of the mice. The detected signal from the tumor was higher than the 
background noise allowing for rapid detection of the tumor. The tumor was clearly visible 
within one hour. Some signal was also detected from the abdomen of the mice. As determined 
by microscopy analysis, other organs of accumulation were the liver and kidney, which cor-
responded well to the data from the whole body imaging animal studies.
Keywords: nanotechnology, nanomedicine, cancer imaging agents, near infrared imaging, 
micelles
Introduction
Near infrared (NIR) planar optical imaging is a powerful, simple, and easy to use 
method that has found increasing use for the observation of biological events. It uses 
the ‘absorbance window’ that exists in the near infrared part of the spectrum where 
light absorption by tissues is negligible. Therefore, light can penetrate up to a few cen-
timeters through the body.1 Using NIR fluorescence and large stokes shift fluorophores 
that eliminate the back scattering of the excitation beam, whole body images of small 
animals can be taken with a better signal-to-noise ratio and greater clarity than in the 
visible spectrum, where light absorption allows only surface imaging. By using new 
highly stable fluorophores, images can be taken at exposure times of minutes and even 
real-time observations can take place,2 so that clear images are produced. For example, 
using this method it was possible to target and image various biological targets, such as 
estrogen growth factor receptors in breast cancer,3 vascular endothelial growth factor 
(VEGF) receptors in tumors and lymph nodes4 before surgery. Since NIR imaging does 
not require the complex instrumentation of other methods, such as positron emission 
tomography (PET) or magnetic resonance imaging (MRI), or the handling procedures 
associated with radioactive materials, it has gained attention for the visualization of 
tumors and cells in vivo, especially using nano-scaled materials. For instance, dendritic 
cells were labeled and monitored using NIR-emitting polymersomes,5 and endothelial 
cells were targeted and visualized using NIR-emitting CD31 antibody.6International Journal of Nanomedicine 2009:4 124
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Although NIR-imaging results in better images than in the 
visible spectrum, it presents some challenges. Thus, there is 
an intense scattering of the fluorescence by tissues, causing 
the distortion of the images and the loss of contrast, which is 
considered the main disadvantage of the NIR planar imaging. 
The quantification of the signal becomes challenging, since 
the scattered light interferes with the measurements. Increas-
ing the signal intensity only worsens the intensity of light 
scattering. All approaches up to now have been focused 
mainly on the elimination of scattering by using various tech-
niques either mathematically, such as in optical tomography, 
or physically, using multispectral imaging.7,8 Despite their 
elegance, these methods require complex instruments that 
make NIR-imaging a less practical choice, while the planar 
imaging is expected be useful in relatively simple everyday 
practice, allowing for the rapid identification of the internal 
structures of living subjects, in situ, and in real time.9 The 
approach is also expected to utilize organic dyes that can be 
safely administered to patients and avoids toxic metals such 
as cadmium or selenium used in quantum dots.10,11 However, 
both the appropriate contrast agent and the means for extrac-
tion of meaningful data from planar images still need to be 
better developed.
Various nanoparticulates have been developed specially 
for the NIR detection and imaging of tumors.12,13 In this con-
text, polymeric micelles represent an established colloidal 
nanocarrier system that has great advantages for the delivery 
of various drugs and vaccines. Micelles self-assemble from 
various amphiphilic molecules upon their hydration and 
remain stable as long as their concentration is above the 
critical micellar concentration (CMC). Lipid-core micelles 
offer high biocompatibility when formed from polyethylene 
glycol–lipid conjugates. They have been used extensively 
for experimental anticancer therapy, especially with poorly 
water soluble drugs, such as paclitaxel or camptothecin, 
with photodynamic therapy, and as an imaging agent.14,15 
Evidently, the micelles can be used as nanocarriers for NIR 
agents, and simultaneously NIR imaging, in turn, can be 
used for the visualization of such biodegradable nanocarriers 
in vivo, offering a direct method for observation of their fate 
(as well as of other different events) inside the body, which 
was previously impossible,16 both at the macroscopic and 
microscopic levels.16
Earlier efforts from our lab used radio-labeling to follow 
the biodistribution of the lipid-core micelles. However, the 
images produced with a gamma-camera were intrinsically 
limited by the low resolution of the gamma-camera and the 
contrast of the images. Tumors were optimally visible only 
after several hours,17 and significant signal intensity was often 
observed from various other internal organs.18–20
Here, we report the use of double-labeled micelles based 
on PEG-phosphatidylethanolamine (PEG-PE) conjugates, 
containing a NIR dye, Alexa 750, and rhodamine to pas-
sively target tumors in vivo and to visualize them with much 
higher detail and precision than previously observed using 
both whole body imaging and fluorescent microscopy. We 
also describe a rapid and simple methodology to evaluate 
the imaging capability of the contrast agent and quantify the 
signal in a comparable way between different time points and 
different animal subjects. The NIR images also provided an 
additional insight into the fate of such micelles in vivo.
Experimental section
Conjugation of Alexa 750 PE 
to phospholipids
Alexa succinimidyl ester (Invitrogen, Carlsbad, CA) was 
dissolved in chloroform and mixed with a 4x excess of 
DOPE-NH2 in the presence of tri-ethylamine, as recommended 
by the manufacturer. The mixture was kept overnight in 
darkness and the product purified by column chromatography 
(stationary phase silica gel, mobile phase chloroform-to-metha-
nol 4:1 to 4:3). Purity of product was tested using thin layer 
chromatography (TLC; stationary phase silica gel, mobile phase 
chloroform-to-methanol 4:3). The conjugation was complete. 
Only Alexa conjugated to lipids was detected by the TLC at 
the end of the procedure (Rf circa 0.6), while no unbound dye, 
co-eluted at the solvent front, was detected.
Micelle preparation
Alexa PE 750 micelles were prepared according to a protocol 
used routinely in our lab. Briefly, a chloroformic solution of 
PEG-PE 5000 was mixed with Alexa 750 PE (0.25% molar) 
and rhodamine lysamine PE (0.25% molar) in a round bottom 
flask (0.55 umole of phospolipids). Solvents were evaporated 
in a rotary evaporator and the lipid film was freeze dried 
overnight. Micelles were produced by hydration of the lipid 
film with phosphate-buffered saline (PBS) pH = 7.4 (0.2 ml) 
followed by bath sonication and a 30 min equilibration period. 
This standard protocol allows for the quantitative incorporation 
of lipid-modified moieties into the micelles formed. The size 
distribution of the micelles was measured using laser diffrac-
tion analysis (Counter N4; Beckman Coulter Inc., Fullerton, 
CA). The average hydrodynamic size of the micelles was 
17.4 ± 3.9 nm. The micelles were stable in PBS, pH = 7.4 for 
a period of up to 15 days after their hydration.International Journal of Nanomedicine 2009:4 125
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Commercially available nanoparticles
Kodak X-sight polymerized nanospheres, encapsulating an 
organic dye (excitation 761 nm, emission 789 (Carestream 
Health, New Haven, CT) were used as is for comparison to 
the Alexa micelles.
Tumor inoculation of mice
Female Balb/c mice (Charles River Laboratories, Wilmington, 
MA) were used, following a protocol approved by Northeast-
ern University Institutional Animal Care and Use Committee 
in accordance with ‘Principles of Laboratory Animal Care’ 
(NIH publication No. 85–23, revised in 1985). Animals had 
free access to food and water. Murine 4T1 breast cancer 
cells were grown in Dulbecco modified Eagle’s medium. 
150,000 cells were suspended in 150 µl of PBS and injected 
subcutaneously over the left flank. Tumors developed within 
a period of two weeks.
Near infrared imaging of mice
Contrast agents, prepared the same day, as described above, 
were injected via the tail vein at concentrations between 55 
and 300 nmol/kg, which is a somewhat smaller dose than used 
with other Alexa-labeled macromolecules (see for example Li 
Peng and colleagues21), however we have compensated the 
decreased dose with an increased exposure time. Mice were 
anesthetized (ketamine/xylazine, i.p.) and depilated (Nair, 
Princeton, NJ). Images were taken using a Kodak Image 
Station In Vivo FX (filters: excitation 710 nm, emission 
790 nm) at different angles with an exposure time of 10 min. 
At the end of the imaging, anesthetized mice were sacrificed, 
skin removed and images retaken. Images of the organs were 
also made, either inside the body or ex vivo. Samples were 
also taken for histological examination.
Image analysis
Images were analyzed using the Kodak Image Analysis 
Software or the NIH Image J software. Dorsal images 
of the animals were analyzed, so that the tumor directly 
faced the camera. Regions of interest (ROI) were determined 
for the tumor area, tumor background, that included tumor, 
liver and spleen sites and over the hip corresponding to the 
intrinsic fluorescence of the animal. The fluorescence mean 
intensities were extracted for each and the signal-to-noise 
ratio for the tumor area was calculated, using the pixel inten-
sity values for the ROIs corresponding to the tumor and the 
local background, so that the fluorescence is presented as 
signal to noise instead of arbitrary pixel intensity values. In 
order to produce comparable data, the signal-to-noise ratio 
was normalized versus the ROI over the hip that represents 
the intrinsic fluorescence of the animal. This compensated 
for the difference in the overall luminosity of the pictures 
due to the differences of biodistribution of the contrast agent 
in the body at different time points.
Histology
Tissue samples from organs and tumor removed from animals 
immediately after their sacrifice were stored at -80 °C. 
Frozen samples were cryo-sectioned at a thickness of 6 µm 
and observed under fluorescence microscopy (excitation 
545 nm). Slices were also stained by eosin and hematoxylin 
and observed with white field microscopy.
Results and discussion
Figure 1 presents a side view of animals injected with Alexa-
labeled micelles (A, B), so that the tumor is directly facing 
the camera. In this view, the tumor area shows higher fluores-
cence compared the area immediately surrounding it and to 
the rest of the body. At one hour, in these mice we observed 
the localized highly contrasted signal from the tumor area, 
and a similar quality image was obtained at two hours. We 
also observed an increasing signal from the abdomen of 
the animal that corresponded to the location of the bladder. 
The fluorescence from the bladder area, although lower at 
one hour compared to the tumor, increased with time. At 
two hours, it became the greater source of the fluorescence 
signal. The anatomical location of the sites emitting the 
fluorescence was verified by imaging of sacrificed animals 
after the skin was removed (data not shown). The quality of 
the images was improved by the choice of the viewing angle. 
The limited penetration of light into tissues during the optical 
imaging was useful, since different parts of the animal could 
be better visualized by reorienting the animal. Tissues that 
lay deeper inside the animal contribute only a diffuse light 
that is fairly uniform and can be eliminated (threshold) with 
great precision. This results in clear identification of features 
that are directly in front of the camera, while other phenom-
ena were easily reduced or eliminated. This is not feasible 
using radio-labeled nanocarriers (micelles) since gamma-
irradiation easily penetrates the tissues. For instance, using 
111In-labeled micelles, the tumor site was visible only after 
significantly longer times and the images were noisy due to 
the high penetration of the gamma-irradiation.20
Figure 2 compares the ventral view of two animals, one 
(C) injected with Alexa-labeled micelles, and another (D) 
injected with the commercially available polymerized nanopar-
ticles encapsulating a near infrared dye. The commercial International Journal of Nanomedicine 2009:4 126
Papagiannaros et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
nanoparticles exhibited a higher signal compared to the 
Alexa-micelles that was more uniformly distributed all over 
the body. The Alexa-labeled micelles exhibited a high signal 
mainly from the area over the bladder of the animal, while 
the commercial nanoparticles’ localization corresponds to 
the liver. The fluorescence intensity observed in the abdomen 
(C) increased with time, doubling in value at between one 
and two hours. By contrast, the fluorescence from the liver 
of the animal D decreased slightly after two hours. The high 
signal in the abdomen, clearly observed in the frontal view 
is suggestive of a dissociation of the micelles, leading to the 
clearance of the near infrared dye. Gamma-camera studies 
with similar  111In-labeled micelles exhibited a very similar 
pattern.22 The pattern of the near infrared emission was also 
similar to studies of the stability of biodegradable nanoparticles 
using near infrared imaging.16 This conclusion is supported 
by the data from the Figure 3 (upper row), which shows a 
much higher deposition of rhodamine (the second label in our 
micelles) in the liver and kidney than in the tumor, suggesting 
the increased clearance of the micelle material through these 
organs. Both the results of the infrared imaging and of the 
whole body imaging suggest that the aggregate nature of the 
micelles contribute to this secretion pattern involving micelle 
dissociation. In Figure 3, lower row, hematoxylin and eosin 
staining of the slices verified the expected morphology of the 
tumor and organs that were free of metastasis. Figure 4 shows 
ex vivo images of one animal at the end of the experiment with 
the skin removed. The image reveals that at the end of the 
experiment, the main sources of fluorescence are the liver, the 
lower part of the gastrointestinal tract, and the bladder area.
Figure 5 shows the quantified background NIR signal 
from the area surrounding the tumor and from the control 
area over the hip using the planar whole body imaging of 
tumor-bearing mice during a four hour period. One can 
notice that neither the background noise from the tumor 
area nor the intrinsic fluorescence of the animal (the signal 
from the control area) remained constant during the imaging 
studies, although the changes in the signal are not dramatic 
or statistically significant in the case of the tumor area. The 
background noise, corresponding largely to the scattered 
light from internal organs (liver and spleen) as well as the 
tumor, initially slightly decreased after the one hour value 
of 1731 ± 88 A.U. As the biodistribution changed, the back-
ground in the organs and tumor slightly increased again at 
5597.27 5940.67 6284.07 6627.47 6970.87 4785.44 5906.36 7027.29 8148.21 9269.13
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B B
Figure 1 Side view of two animals (A and B) injected with Alexa-labeled micelles, at one hour (left) and two hours (right) after the injection. Arrows point to the tumor.International Journal of Nanomedicine 2009:4 127
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Figure 2 Ventral view of the animal injected with Alexa-labeled micelles (C) and another animal injected with Kodak X-Sight 761 (D), at one hour (left) and two hours (right) 
after the injection.
Tumor Kidney Liver
Figure 3 Cryosections of tumor, kidney, and liver removed from the animals injected with Alexa rhodamine-labeled micelles. Upper row: fluorescence microscopy imaging of 
rhodamine accumulation. Lower row: white field images of eosin and hematoxylin-stained sections.International Journal of Nanomedicine 2009:4 128
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the end of the experiment to 1847 ± 112 A.U. On the other 
hand, the fluorescence signal from the animal body (control 
area) increased during the experiment, from 1542 ± 77 at one 
hour to 1900 ± 105 at four hours. The quantification of the 
signal in this case represents a major improvement, since it 
is based on normalized signal-to-noise data. This is a clear 
advantage over previous attempts with photons/gram of 
tissue using ex vivo data from organs excised from animals 
after the imaging.16 The inclusion of the whole body imaging 
and the generation of the data from all selected time points 
from the same animal decreased the variability of the mea-
surements and augmented the physical relevance of the data. 
Whole body images provided an objective description of the 
imaging capacity of the set-up and the contrast agent and aug-
mented the ability to make objective comparisons between 
different contrast agents. This was achieved because the 
two prime factors that introduce variability in the measure-
ments were addressed: a) the difference in the background 
noise due to the time-dependent changes in the distribution 
of the agent in the body, and b) the difference in the overall 
luminosity of the image as the agent cleared from the animal. 
The normalization of the data is of critical importance for 
obtaining comparable results.23 In fact, multispectral imaging 
uses the data from different wavelengths that offer the same 
mechanism of normalization as the one employed here, since 
it compensates for the differences in the images during the 
course of imaging.24 The data obtained are still not as good 
as in case of the tomographic imaging. However, the main 
result here is the minimizing the effect of the background 
noise on the quality of the data. For instance, early work in 
the tomographic field concentrated on the effect of math-
ematical subtraction of noise, especially in heterogeneous 
media,25 or the normalization of the Born approximation ratio 
for the scattering of the fluorescence throughout the animal 
body.26 This approximation method successfully generated 
3-D reconstructions of small animals27 and the quantification 
of the antitumor effect of treatment in vivo.28
Figure 6 shows that the signal-to-noise ratio from the 
Alexa-labeled micelles at the tumor remained higher than of 
areas near the tumor. It reached a value of 1.3 ± 0.07 within 
one hour and it remained at similar levels until the end of 
the experiment, reaching a value of 1.6 ± 0.08 at four hours. 
The signal-to-noise ratio was influenced by the different 
values obtained from the tissues surrounding the tumor ROI. 
The overall fluorescence of the animal remained high despite 
the fluctuations in the later values. We achieved the above 
mentioned high signal at the tumor site after only one hour 
of imaging, which allowed us to pinpoint the tumor site, so 
that its dimensions and boundaries were clearly defined. This 
signal was also higher than the surrounding tissues, such as 
594.71 665.02 735.34 805.65 875.97
Bladder Liver
G.I.
Figure 4 Ventral view of an animal injected with Alexa-labeled micelles at the end of the experiment with the skin removed. Tumor is visible in the side of the animal.International Journal of Nanomedicine 2009:4 129
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liver, where all nanoparticles tend to accumulate. This looks 
like a clear advantage of our version of the NIR optical imag-
ing that allowed for the production of high quality images with 
a relatively simple and inexpensive instrument (in comparison 
to a gamma-camera or MRI system) and involved the use of 
environmentally friendly and less hazardous dyes. In addi-
tion, informative images can be obtained rather fast, which 
decreases the exposure of the subject to the contrast agent.
The imaging of polymeric near infrared dye-encapsulating 
commercial nanoparticles (Figure 2, lower row), showed a 
high localized signal in the liver but not in the bladder. Lipid 
nanoparticles, such as liposomes, have been used to monitor 
the extravasation of nanoparticles through the tumor vessels.29 
Polymerosomes used for cell labeling remained intact and 
light-excitable inside the cells.5 Similar ‘monolithic’ nanopar-
ticles can be much more appropriate for cell trafficking studies 
than nanoparticles made of inorganic materials such as quan-
tum dots, due to their different toxicological profile.
To the best of our knowledge, our results present the 
first lipid-core micellar nanocarrier system using near infra-
red dyes for the whole body imaging. Recent research has 
emphasized the use of block copolymers to stabilize the 
easily degradable near infrared dye, indocyanine green.30 
Low density lipoprotein used for breast tumor visualization 
in vivo using confocal microscopy,31 was found to remain dis-
persed in the circulation, despite the presence of endogenous 
low-density lipoprotein. Finally, cross-linked micelle-like 
structures made of synthetic polymers allowed visualization 
of breast cancer xenographs, both in near infrared and using 
gamma-imaging.32
The major result of these experiments was the produc-
tion of high quality images using organic dyes conjugated to 
nanosized micelles. They can produce high signal intensity 
that may be useful to visualize a variety of events, such as 
tumor uptake through an altered microcirculation.33 In case 
of quantum dots, despite their advantages in terms of opti-
cal quality, contrast and clarity, their use is hampered by 
serious toxicological implications, including the degrada-
tion of toxic metals within the cells.34–36 Previous work on 
near infrared imaging using labeled macromolecules had 
the disadvantage of low signal intensity and poor quality 
images.4,12 The conjugation of multiple molecules of near 
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Figure 5 Fluorescence intensity of the background signal around the tumor and the intrinsic fluorescence of the animal body (control region of interest [ROI] over hip). The 
overall signal fluctuated with time as the biodistribution of the contrast agent changed.
Notes: N = 6; bars represent standard error of the mean.International Journal of Nanomedicine 2009:4 130
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infrared dyes within micellar nanoparticles provides the 
means to increase the signal intensity and allows good signal 
quantification. In conclusion, this work demonstrates that the 
quantification of the accumulation of a contrast agent can 
be achieved using simple (and more relevant to everyday 
practice) instruments, and that highly biocompatible lipid-
core PEG-PE-based micelles are convenient nanocarriers for 
NIR contrast agents.
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